NCT06182852View on ClinicalTrials.gov

The Effect of GLP-1 Receptor Agonist on Bone Metabolism in Patients With Diabetes Mellitus

Not yet recruitingOBSERVATIONAL
Enrollment

330

Participants

Timeline

Start Date

January 1, 2024

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2025

Conditions
Diabete Type 2Bone Metabolism
Trial Locations (1)

210006

Nanjing First Hospital, Nanjing Medical Univesity, Nanjing

All Listed Sponsors
lead

Nanjing First Hospital, Nanjing Medical University

OTHER

NCT06182852 - The Effect of GLP-1 Receptor Agonist on Bone Metabolism in Patients With Diabetes Mellitus | Biotech Hunter | Biotech Hunter